Iris M. Seignette

497 total citations
9 papers, 78 citations indexed

About

Iris M. Seignette is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Iris M. Seignette has authored 9 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Immunology. Recurrent topics in Iris M. Seignette's work include Cancer Immunotherapy and Biomarkers (3 papers), Erythrocyte Function and Pathophysiology (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Iris M. Seignette is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Erythrocyte Function and Pathophysiology (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Iris M. Seignette collaborates with scholars based in Netherlands, Germany and Iceland. Iris M. Seignette's co-authors include Peter C. Ligthart, Thomas R. Klei, Robin van Bruggen, Paul J.J.H. Verkuijlen, Simon Horenblas, Michiel S. van der Heijden, Bas W.G. van Rhijn, Alberto Gil-Jimenez, Annegien Broeks and Hielke M. de Vries and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Iris M. Seignette

8 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris M. Seignette Netherlands	4	38	24	17	16	16	9	78
Isabelle Brown United States	6	26 0.7×	13 0.5×	5 0.3×	7 0.4×	18 1.1×	15	127
Jordan R. Portman United Kingdom	3	20 0.5×	20 0.8×	8 0.5×	17 1.1×	11 0.7×	3	105
Coline HM van Moorsel Netherlands	6	25 0.7×	28 1.2×	54 3.2×	10 0.6×	13 0.8×	9	87
Laurence Olivier-Faivre France	3	20 0.5×	21 0.9×	12 0.7×	10 0.6×	11 0.7×	6	73
Saul Offman Canada	5	64 1.7×	8 0.3×	20 1.2×	11 0.7×	5 0.3×	10	115
Sara Lettieri Italy	7	17 0.4×	17 0.7×	76 4.5×	21 1.3×	12 0.8×	22	114
Alexia Loste France	2	11 0.3×	14 0.6×	6 0.4×	15 0.9×	4 0.3×	4	86
Gloria Liliana Porras-Hurtado Colombia	6	15 0.4×	23 1.0×	8 0.5×	19 1.2×	4 0.3×	16	90
Yiqun Yang China	5	11 0.3×	9 0.4×	10 0.6×	33 2.1×	5 0.3×	21	95
María Jesús García-Villanueva Spain	6	12 0.3×	8 0.3×	17 1.0×	18 1.1×	7 0.4×	12	86

Countries citing papers authored by Iris M. Seignette

Since Specialization

Citations

This map shows the geographic impact of Iris M. Seignette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris M. Seignette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris M. Seignette more than expected).

Fields of papers citing papers by Iris M. Seignette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris M. Seignette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris M. Seignette. The network helps show where Iris M. Seignette may publish in the future.

Co-authorship network of co-authors of Iris M. Seignette

This figure shows the co-authorship network connecting the top 25 collaborators of Iris M. Seignette. A scholar is included among the top collaborators of Iris M. Seignette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris M. Seignette. Iris M. Seignette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Vos, Joris L., Joleen J.H. Traets, Xiaohang Qiao, et al.. (2024). Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma. JCI Insight. 9(21). 5 indexed citations

Wilpe, Sandra van, Iris M. Seignette, Alberto Gil-Jimenez, et al.. (2024). Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment. Clinical Cancer Research. 30(18). 4227–4239. 3 indexed citations

Sandick, Johanna W. van, Willem J. Koemans, Tom van den Bosch, et al.. (2024). Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomas. Cell Reports. 43(11). 114981–114981.

Dijk, Nick van, Maurits L. van Montfoort, Iris M. Seignette, et al.. (2024). Clinical efficacy and biomarker analysis of pre-operative ipilimumab plus nivolumab in stage III urothelial cancer: The NABUCCO trial update.. Journal of Clinical Oncology. 42(16_suppl). 4593–4593. 1 indexed citations

Berg, José G. van den, Pétur Snæbjörnsson, Iris M. Seignette, et al.. (2023). Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment. Frontiers in Oncology. 13. 1209732–1209732. 3 indexed citations

Vries, Hielke M. de, Alberto Gil-Jimenez, Jeantine M. de Feijter, et al.. (2023). Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. Journal of Clinical Oncology. 41(31). 4872–4880. 34 indexed citations

Disselhorst, Maria, Yoni Lubeck, Vincent van der Noort, et al.. (2022). Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?. Lung Cancer. 173. 49–52. 1 indexed citations

Klei, Thomas R., Boukje M. Beuger, Paul J.J.H. Verkuijlen, et al.. (2020). The Gardos effect drives erythrocyte senescence and leads to Lu/BCAM and CD44 adhesion molecule activation. Blood Advances. 4(24). 6218–6229. 24 indexed citations

Klei, Thomas R., Francesca Aglialoro, Erik Mul, et al.. (2019). Differential interaction between DARC and SDF-1 on erythrocytes and their precursors. Scientific Reports. 9(1). 16245–16245. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact